List of Tables
Table 1. Global Cushing’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Ketoconazole
Table 3. Key Players of Mitotane
Table 4. Key Players of Aminoglutethimide
Table 5. Key Players of Metyrapone
Table 6. Key Players of Mifepristone
Table 7. Key Players of Etomidate
Table 8. Key Players of Pasireotide
Table 9. Global Cushing’s Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Cushing’s Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Cushing’s Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Cushing’s Disease Treatment Market Share by Region (2020-2025)
Table 13. Global Cushing’s Disease Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Cushing’s Disease Treatment Market Share by Region (2026-2031)
Table 15. Cushing’s Disease Treatment Market Trends
Table 16. Cushing’s Disease Treatment Market Drivers
Table 17. Cushing’s Disease Treatment Market Challenges
Table 18. Cushing’s Disease Treatment Market Restraints
Table 19. Global Cushing’s Disease Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Cushing’s Disease Treatment Market Share by Players (2020-2025)
Table 21. Global Top Cushing’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cushing’s Disease Treatment as of 2024)
Table 22. Ranking of Global Top Cushing’s Disease Treatment Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Cushing’s Disease Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Cushing’s Disease Treatment, Headquarters and Area Served
Table 25. Global Key Players of Cushing’s Disease Treatment, Product and Application
Table 26. Global Key Players of Cushing’s Disease Treatment, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cushing’s Disease Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Cushing’s Disease Treatment Revenue Market Share by Type (2020-2025)
Table 30. Global Cushing’s Disease Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Cushing’s Disease Treatment Revenue Market Share by Type (2026-2031)
Table 32. Global Cushing’s Disease Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Cushing’s Disease Treatment Revenue Market Share by Application (2020-2025)
Table 34. Global Cushing’s Disease Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Cushing’s Disease Treatment Revenue Market Share by Application (2026-2031)
Table 36. North America Cushing’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Cushing’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Cushing’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Cushing’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Cushing’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Cushing’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Cushing’s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Cushing’s Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Cushing’s Disease Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Cushing’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Cushing’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Cushing’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Cushing’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Cushing’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Cushing’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 51. CORCEPT THERAPEUTICS Company Details
Table 52. CORCEPT THERAPEUTICS Business Overview
Table 53. CORCEPT THERAPEUTICS Cushing’s Disease Treatment Product
Table 54. CORCEPT THERAPEUTICS Revenue in Cushing’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 55. CORCEPT THERAPEUTICS Recent Development
Table 56. HRA Pharma Company Details
Table 57. HRA Pharma Business Overview
Table 58. HRA Pharma Cushing’s Disease Treatment Product
Table 59. HRA Pharma Revenue in Cushing’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 60. HRA Pharma Recent Development
Table 61. Strongbridge Biopharma Company Details
Table 62. Strongbridge Biopharma Business Overview
Table 63. Strongbridge Biopharma Cushing’s Disease Treatment Product
Table 64. Strongbridge Biopharma Revenue in Cushing’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 65. Strongbridge Biopharma Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Cushing’s Disease Treatment Product
Table 69. Novartis Revenue in Cushing’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
Table 74. Authors List of This Report
List of Figures
Figure 1. Cushing’s Disease Treatment Picture
Figure 2. Global Cushing’s Disease Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cushing’s Disease Treatment Market Share by Type: 2024 VS 2031
Figure 4. Ketoconazole Features
Figure 5. Mitotane Features
Figure 6. Aminoglutethimide Features
Figure 7. Metyrapone Features
Figure 8. Mifepristone Features
Figure 9. Etomidate Features
Figure 10. Pasireotide Features
Figure 11. Global Cushing’s Disease Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Cushing’s Disease Treatment Market Share by Application: 2024 VS 2031
Figure 13. Hospital Pharmacies Case Studies
Figure 14. Retail Pharmacies Case Studies
Figure 15. Drug Stores Case Studies
Figure 16. Clinics Case Studies
Figure 17. E-Commerce/Online Pharmacies Case Studies
Figure 18. Cushing’s Disease Treatment Report Years Considered
Figure 19. Global Cushing’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Cushing’s Disease Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Cushing’s Disease Treatment Market Share by Region: 2024 VS 2031
Figure 22. Global Cushing’s Disease Treatment Market Share by Players in 2024
Figure 23. Global Top Cushing’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cushing’s Disease Treatment as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Cushing’s Disease Treatment Revenue in 2024
Figure 25. North America Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America Cushing’s Disease Treatment Market Share by Country (2020-2031)
Figure 27. United States Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Cushing’s Disease Treatment Market Share by Country (2020-2031)
Figure 31. Germany Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Nordic Countries Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Cushing’s Disease Treatment Market Share by Region (2020-2031)
Figure 39. China Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Cushing’s Disease Treatment Market Share by Country (2020-2031)
Figure 47. Mexico Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Cushing’s Disease Treatment Market Share by Country (2020-2031)
Figure 51. Turkey Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE Cushing’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. CORCEPT THERAPEUTICS Revenue Growth Rate in Cushing’s Disease Treatment Business (2020-2025)
Figure 55. HRA Pharma Revenue Growth Rate in Cushing’s Disease Treatment Business (2020-2025)
Figure 56. Strongbridge Biopharma Revenue Growth Rate in Cushing’s Disease Treatment Business (2020-2025)
Figure 57. Novartis Revenue Growth Rate in Cushing’s Disease Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
